All trading involves risk. Contracts for Difference (CFDs) are complex instruments and may not be suitable for all investors. Please refer to Risk Disclosure and Risk Fact Sheet on Capital.com/en-sg.
Open platformOpen platform

BeyondSpring swings to Q3 net income of $50.49 million

By Public Technologies
  • BeyondSpring swung to third-quarter net income attributable to shareholders of $50.79 million from a year-earlier loss.
  • Results included a $53.67 million gain on the sale of subsidiary interests.
  • Cash, cash equivalents and short-term investments fell 85% to $580,000 at September 30 from December 31, 2025.
  • The FDA granted Fast Track designation to Plinabulin with docetaxel for previously treated non-squamous lung cancer without actionable genomic alterations.
  • A completed transaction with Biolin provides funding support for approximately half of DUBLIN-4's planned 442-patient enrollment.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BeyondSpring Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611131715PRIMZONEFULLFEED9877655) on November 13, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.